发明名称 COMPOSITION OF SOLIFENACIN OR SALT THEREOF FOR USE IN SOLID FORMULATION
摘要 <p>A solid pharmaceutical preparation of solifenacin or a salt thereof, the preparation being stable and inhibited from decomposing with time when supplied to clinical fields. In a pharmaceutical preparation containing solifenacin or a salt thereof, the compound in an amorphous form was revealed to be causative of cardinal-drug decomposition with time. The composition for a solid pharmaceutical preparation of solifenacin or a salt thereof contains solifenacin or its salt each in a crystalline from, and the content provided are: a process for producing the composition; and a medicinal composition for solid pharmaceutical preparations which contains solifenacin and an amorphization inhibitor.</p>
申请公布号 PT2156824(E) 申请公布日期 2013.01.04
申请号 PT20090014500T 申请日期 2005.03.24
申请人 ASTELLAS PHARMA INC. 发明人 AKIO SUGIHARA;TAKEHIKO YASUJI;KATSUHIRO MASAKI;DAISUKE MURAYAMA
分类号 A61K9/20;A61K31/439;A61K47/34;A61P1/12;A61P13/02;A61P27/08;C07D453/02 主分类号 A61K9/20
代理机构 代理人
主权项
地址